Abiopharma

Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer

Cerus Corporation - Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

Janux - Investor Relations - Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights

MindMed Reports Q3 2025 Financial Results and Business Updates

Curis Provides Third Quarter 2025 Business Update

SIGA - SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025

Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders Equity Deficiency

Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress

Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update